Oncology Institute (TOI) Competitors $0.21 +0.00 (+1.55%) (As of 12/20/2024 05:51 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends TOI vs. ENZ, CCM, MRAI, PMD, BRTX, OPGN, KDLY, OTRK, MGRX, and VSEEShould you be buying Oncology Institute stock or one of its competitors? The main competitors of Oncology Institute include Enzo Biochem (ENZ), Concord Medical Services (CCM), Marpai (MRAI), Psychemedics (PMD), BioRestorative Therapies (BRTX), OpGen (OPGN), Kindly MD (KDLY), Ontrak (OTRK), Mangoceuticals (MGRX), and Vsee Health (VSEE). These companies are all part of the "healthcare" industry. Oncology Institute vs. Enzo Biochem Concord Medical Services Marpai Psychemedics BioRestorative Therapies OpGen Kindly MD Ontrak Mangoceuticals Vsee Health Oncology Institute (NASDAQ:TOI) and Enzo Biochem (NYSE:ENZ) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, profitability, media sentiment, earnings, community ranking, dividends and institutional ownership. Which has better earnings & valuation, TOI or ENZ? Enzo Biochem has lower revenue, but higher earnings than Oncology Institute. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOncology Institute$378.93M0.04-$83.07M-$0.78-0.27Enzo Biochem$30.31M1.31-$26.08MN/AN/A Which has more volatility and risk, TOI or ENZ? Oncology Institute has a beta of 0.43, meaning that its stock price is 57% less volatile than the S&P 500. Comparatively, Enzo Biochem has a beta of 0.75, meaning that its stock price is 25% less volatile than the S&P 500. Do analysts prefer TOI or ENZ? Oncology Institute presently has a consensus price target of $2.50, indicating a potential upside of 1,089.91%. Given Oncology Institute's stronger consensus rating and higher probable upside, equities analysts plainly believe Oncology Institute is more favorable than Enzo Biochem.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Oncology Institute 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Enzo Biochem 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community believe in TOI or ENZ? Enzo Biochem received 208 more outperform votes than Oncology Institute when rated by MarketBeat users. However, 66.67% of users gave Oncology Institute an outperform vote while only 54.78% of users gave Enzo Biochem an outperform vote. CompanyUnderperformOutperformOncology InstituteOutperform Votes466.67% Underperform Votes233.33% Enzo BiochemOutperform Votes21254.78% Underperform Votes17545.22% Do institutionals and insiders hold more shares of TOI or ENZ? 36.9% of Oncology Institute shares are held by institutional investors. Comparatively, 36.9% of Enzo Biochem shares are held by institutional investors. 9.5% of Oncology Institute shares are held by company insiders. Comparatively, 11.4% of Enzo Biochem shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the media favor TOI or ENZ? In the previous week, Enzo Biochem had 3 more articles in the media than Oncology Institute. MarketBeat recorded 6 mentions for Enzo Biochem and 3 mentions for Oncology Institute. Oncology Institute's average media sentiment score of -0.15 beat Enzo Biochem's score of -0.35 indicating that Oncology Institute is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Oncology Institute 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Enzo Biochem 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Is TOI or ENZ more profitable? Oncology Institute has a net margin of -17.63% compared to Enzo Biochem's net margin of -81.73%. Enzo Biochem's return on equity of -11.84% beat Oncology Institute's return on equity.Company Net Margins Return on Equity Return on Assets Oncology Institute-17.63% -186.83% -34.58% Enzo Biochem -81.73%-11.84%-8.31% SummaryEnzo Biochem beats Oncology Institute on 9 of the 16 factors compared between the two stocks. Ad Weiss RatingsBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $125,000 by the end of his first month in office.This could be his favorite coin. Get Oncology Institute News Delivered to You Automatically Sign up to receive the latest news and ratings for TOI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TOI vs. The Competition Export to ExcelMetricOncology InstituteOffices & clinics of medical doctors IndustryMedical SectorNASDAQ ExchangeMarket Cap$15.88M$999.93M$5.12B$9.07BDividend YieldN/AN/A4.91%4.22%P/E Ratio-0.2711.9191.3417.19Price / Sales0.041.311,116.63116.80Price / CashN/A42.9742.5837.86Price / Book0.277.884.794.78Net Income-$83.07M-$52.07M$120.07M$225.60M7 Day Performance-5.74%-5.17%-1.90%-1.24%1 Month Performance35.55%0.17%11.43%3.06%1 Year Performance-87.64%-18.32%30.59%16.50% Oncology Institute Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TOIOncology Institute2.4584 of 5 stars$0.21+1.5%$2.50+1,089.9%-88.1%$15.88M$378.93M-0.27660ENZEnzo Biochem0.7816 of 5 stars$1.02-0.5%N/A-46.7%$53.03M$31.91M0.00520Earnings ReportAnalyst ForecastCCMConcord Medical Services0.3788 of 5 stars$4.89-1.2%N/A-58.8%$21.23M$471.70M0.00970Analyst ForecastNews CoverageMRAIMarpaiN/A$1.20-4.0%$6.00+400.0%-47.7%$16.49M$34.87M-0.42150Gap UpPMDPsychemedics1.4054 of 5 stars$2.67-1.8%N/A-5.3%$15.73M$22.10M0.00140Insider TradeGap DownHigh Trading VolumeBRTXBioRestorative Therapies3.4511 of 5 stars$1.45flat$18.00+1,141.4%-11.4%$10.03M$150,000.00-0.917Positive NewsOPGNOpGenN/A$1.07-3.6%N/A-82.8%$8.95M$3.42M0.00100Analyst ForecastNews CoverageKDLYKindly MDN/A$1.23-5.4%N/AN/A$7.35M$2.88M0.00N/AGap DownOTRKOntrak2.6191 of 5 stars$1.59-3.0%$45.00+2,730.2%-76.2%$6.71M$11.24M-0.15250Positive NewsMGRXMangoceuticals1.184 of 5 stars$2.55-2.3%N/A-96.2%$6.34M$755,000.00-0.453News CoveragePositive NewsGap DownVSEEVsee HealthN/A$1.39-6.7%N/AN/A$5.01M$6.38M0.00N/ANews Coverage Related Companies and Tools Related Companies Enzo Biochem Alternatives Concord Medical Services Alternatives Marpai Alternatives Psychemedics Alternatives BioRestorative Therapies Alternatives OpGen Alternatives Kindly MD Alternatives Ontrak Alternatives Mangoceuticals Alternatives Vsee Health Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TOI) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Oncology Institute, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncology Institute With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TOI Stock Alerts